<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
- --------------------------------------------------------------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(AMENDMENT NO. 1)*
Xomed Surgical Products, Inc.
- --------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock
- --------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
98412V107
- --------------------------------------------------------------------------------
(CUSIP NUMBER)
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/X/ Rule 13d-1(b)
/ / Rule 13d-1(c)
/ / Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5
<PAGE>
CUSIP NO.
98412V107
- --------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
Hartford Capital Appreciation HLS Fund, Inc.
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(entities only) 22-2481744
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Maryland
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES -----------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH -----------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH:
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (see instructions)
IV
- --------------------------------------------------------------------------------
Page 2 of 5
<PAGE>
CUSIP NO.
98412V107
- --------------
Item 1(a). Name of Issuer:
Xomed Surgical Products, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
6743 Southpoint Drive, North
Jacksonville, FL 32216-0980
Item 2(a). Name of Person(s) Filing:
Hartford Capital Appreciation HLS Fund, Inc.
Item 2(b). Address of Principal Business Office or; if none, residence:
200 Hopmeadow Street
Simsbury, CT 06070
Item 2(c). Citizenship:
Maryland
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
98412V107
Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:
(a) / / Broker or Dealer registered under Section 15 of the Act
(b) / / Bank as defined in Section 3(a)(6) of the Act
(c) / / Insurance Company as defined in Section 3(a) (19) of the
Act
(d) /X/ Investment Company registered under Section 8 of the
Investment Company Act
(e) / / Investment Adviser registered under Section 203 of the
Investment Company Act of 1940
Page 3 of 5
<PAGE>
CUSIP NO.
98412V107
- --------------
(f) / / Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income Security
Act of 1974 or Endowment Fund; see Rule 13d(1)(ii)(F)
(g) / / Parent Holding Company, in accordance with Rule
13d-1(b)(ii)(G) (Note: See Item 7)
(h) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(H)
Item 4. Ownership:
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer
identified in Item 1.
(a) Amount Beneficially Owned
------------
(b) Percent of Class %
-----
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
-------------------------------------
(ii) shared power to vote or to direct the vote
-------------------------------------
(iii) sole power to dispose or to direct the
disposition of
-------------------------------------
(iv) shared power to dispose or to direct the
disposition of
-------------------------------------
Item 5. Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following: (X)
Page 4 of 5
<PAGE>
CUSIP NO.
98412V107
- --------------
Item 6. Ownership of More than Five Percent on behalf of Another Person:
N/A
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security being Reported on by the Parent Holding
Company: N/A
Item 8. Identification and Classification of Members of the Group: N/A
Item 9. Notice of Dissolution of Group: N/A
Item 10. Certification:
By signing below I certify that to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
Signature
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
DATE: February 9, 1999
----------------
Hartford Capital Appreciation HLS Fund, Inc.
BY: /s/ Joseph H. Gareau
--------------------
Joseph H. Gareau
President
Page 5 of 5
